文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

较低与较高呼气末正压策略对无急性呼吸窘迫综合征ICU患者临床相关结局的影响:RELAx随机临床试验的贝叶斯再分析

Effect of a Lower Vs. Higher Positive End-Expiratory Pressure Strategy on Clinically Relevant Outcomes in ICU Patients Without Acute Respiratory Distress Syndrome: Bayesian Re-analysis of the REstricted Vs. Liberal Positive End-Expiratory Pressure in Patients Without Acute Respiratory Distress Syndrome (RELAx) Randomized Clinical Trial.
PubMed 文献 · Crit Care Med · 2026-03-31
一句话结论RELAx贝叶斯再分析显示,无ARDS的机械通气患者中较低PEEP(0-5 cm H₂O)较8 cm H₂O在总体人群获益概率仅中等,但在非心脏骤停入院或非呼吸衰竭插管亚组获益概率超过90%。

本研究为RELAx试验的事后贝叶斯再分析,纳入8个ICU于2017年10月至2019年3月期间收治的980例预期需要有创机械通气≥24小时且非ARDS的危重患者,随机接受最低可能PEEP(0-5 cm H₂O)或较高PEEP(8 cm H₂O)。主要终点为28天无呼吸机天数(VFD-28),较低PEEP的比值比为1.08(95%可信区间0.87-1.35),各先验下优势概率为75%-78%。28天死亡率获益概率为72%-89%,通气时长获益概率仅11%-28%;在非心脏骤停入院或非呼吸衰竭插管的亚组中,较低PEEP获益概率超过90%。作者认为总体获益概率中等,但特定亚组可能更高,提示疗效异质性并支持进一步研究。

要点

  • 在无ARDS的ICU机械通气患者中,较低PEEP(0-5 cm H₂O)对比8 cm H₂O的VFD-28比值比为1.08(95%可信区间0.87-1.35),优势概率75%-78%。
  • 较低PEEP对28天死亡率的获益概率为72%-89%,对通气时长的获益概率仅11%-28%。
  • 非心脏骤停入院或非呼吸衰竭插管的亚组中,较低PEEP获益概率超过90%,提示疗效异质性。
  • 该分析为RELAx试验的事后贝叶斯再分析,总体获益概率中等,作者支持进一步研究。

适用人群与场景

  • 预期需要有创机械通气≥24小时且非ARDS的ICU危重患者,RELAx试验共纳入980例。
  • 亚组分析关注非心脏骤停入院或非呼吸衰竭插管的患者,该亚组较低PEEP获益概率超过90%。

处置流程与药物剂量

  • 较低PEEP策略:随机分配至最低可能PEEP,范围0-5 cm H₂O。
  • 较高PEEP策略:随机分配至PEEP 8 cm H₂O。

研究设计与关键结果

  • 研究类型:RELAx随机临床试验的事后贝叶斯再分析,RELAx为多中心非劣效性试验,于2017年10月至2019年3月在8个ICU进行,共980例患者。
  • 干预与对照:较低PEEP(0-5 cm H₂O)vs 较高PEEP(8 cm H₂O)。
  • 主要终点:28天无呼吸机天数(VFD-28),较低PEEP的比值比为1.08(95%可信区间0.87-1.35),各先验下优势概率75%-78%。
  • 关键次要终点:28天死亡率获益概率72%-89%,通气时长获益概率11%-28%。
  • 亚组:非心脏骤停入院或非呼吸衰竭插管的患者中,较低PEEP获益概率超过90%。

证据类型、等级与局限

  • 证据类型:随机临床试验(RELAx)的事后贝叶斯再分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在无ARDS的ICU机械通气患者中,较低PEEP(0-5 cm H₂O)与较高PEEP(8 cm H₂O)相比,总体获益概率中等(VFD-28优势概率75%-78%),作者认为特定亚组(非心脏骤停入院或非呼吸衰竭插管)获益概率更高,支持进一步研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: The "REstricted vs. Liberal positive end-expiratory pressure in patients without Acute Respiratory Distress Syndrome (ARDS)" (RELAx) trial compared lower vs. higher positive end-expiratory pressures (PEEP) in invasively ventilated critically ill patients without ARDS, concluding non-inferiority of lower PEEP in frequentist analysis. This study aimed to perform a Bayesian re-analysis of RELAx to assess probabilities of clinically meaningful differences between lower and higher PEEP.

DESIGN: A post hoc Bayesian analysis of RELAx data.

SETTING: RELAx was a non-inferiority multicenter trial conducted between October 2017 and March 2019 in eight ICUs.

PATIENTS: The trial included 980 ICU patients expected to require invasive mechanical ventilation greater than or equal to 24 hours for reasons other than ARDS. All patients included in the original analysis entered the Bayesian re-analysis.

INTERVENTIONS: Participants were randomized to the lowest possible PEEP between 0 and 5 cm H 2 O or to a higher PEEP of 8 cm H 2 O.

MEASUREMENTS AND MAIN RESULTS: The primary outcome was ventilator-free days at day 28 (VFD-28). Secondary outcomes were 28-day mortality and ventilation duration. The odds ratio for higher VFD-28 with lower PEEP was 1.08 (95% credible intervals, 0.87-1.35), with consistent estimates across priors and with a probability of superiority ranging from 75% to 78%. For 28-day mortality and duration of ventilation, the probability of benefit of the lower-PEEP strategy ranged from 72% to 89%, and from 11% to 28%, respectively. In patients admitted for other reasons than cardiac arrest or intubated for other reasons than respiratory failure, probabilities of benefit with lower PEEP exceeded 90%.

CONCLUSIONS: Although the probability of benefit in the overall population was modest, the analysis suggested a higher probability of benefit in selected subgroups, particularly patients admitted for other reasons than cardiac arrest or intubated for other reasons than respiratory failure. These findings highlight potential heterogeneity of treatment effect and support further investigations.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Caroli A, Algera AG, van Meenen D, et al. Effect of a Lower Vs. Higher Positive End-Expiratory Pressure Strategy on Clinically Relevant Outcomes in ICU Patients Without Acute Respiratory Distress Syndrome: Bayesian Re-analysis of the REstricted Vs. Liberal Positive End-Expiratory Pressure in Patients Without Acute Respiratory Distress Syndrome (RELAx) Randomized Clinical Trial. Crit Care Med. 2026. PMID: 41914828. doi:10.1097/CCM.0000000000007117

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。